Industry Data & Market Research

2022 U.S. Industry Statistics & Market Research - Pharmaceutical Preparation Manufacturing

Market Size & Industry Statistics

The total U.S. industry market size for Pharmaceutical Preparation Manufacturing: Industry statistics cover all companies in the United States, both public and private, ranging in size from small businesses to market leaders. In addition to revenue, the industry market analysis shows information on employees, companies, and average firm size.

Investors, banks, and business executives use growth rates and industry trends to understand the market outlook and opportunity.

Pharmaceutical Preparation Manufacturing market size 2022
Charts and graphs can be copied to Microsoft Word and Powerpoint presentations.

Statistics 2016        2017        2018        2019        2020        2021
Market Size
(Total Sales/Revenue)

Order at top of page
Total Firms
Total Employees
Average Revenue Per Firm
Average Employees Per Firm
Average Revenue Per Employee
Statistics Source: U.S. Census, AnythingResearch Analysis of Federal Data

Market Forecast

Market forecasts show the long term industry outlook and future growth trends. The following extended five-year / six-year demand forecast projects both short-term and long-term trends.

Forecast / Industry Outlook 2022 2023 2024 2025 2026
Market Forecast ($ millions)
Projected Industry Growth Rate (%)
Source: AnythingResearch Economic Analysis

Product & Services Breakdown

Research products and services in the Pharmaceutical Preparation Manufacturing industry generating sales. Note that products are broken into categories with different levels of classification.

Product Description Sales ($ millions) Percent of Total Sales

Industry Total

Medicinal And Botanical Manufacturing

Synthetic Organic Medicinal Chemicals (All Uses), Medicinal And Botanical Drugs, Chemicals, And Products, In Bulk, Alkaloid Drug

Pharmaceutical Preparation Manufacturing

Pharmaceutical Preparations, Acting On The Central Nervous System And The Sense Organs, For Human Use

Pharmaceutical Preparations, Acting On The Cardiovascular System, For Human Use

Pharmaceutical Preparations, Acting On The Respiratory System, For Human Use

Pharmaceutical Preparations, Acting On Skin, For Human Use

Pharmaceutical Preparations, Vitamin, Nutrient, And Hematinic Preparations, For Human Use

Pharmaceutical Preparations, Affecting Parasitic And Infective Diseases, For Human Use (Excluding Diagnostics)

Pharmaceutical Preparation Manufacturing, Not Categorized, Total

Biological Product (Except Diagnostic) Manufacturing

Other Biologics, Excluding Diagnostic, For Human Use

Toilet Preparation Manufacturing

Creams, Lotions And Oils, Excluding Shaving, Hair, And Deodorant

Total Miscellaneous Receipts

Resales - Sales Of Products Bought And Sold Without Further Manufacture, Processing, Or Assembly

Contract Work - Receipts For Work Done For Others On Their Materials

Miscellaneous Receipts, Including Receipts For Repair Work, Sales Of Scrap And Refuse.

U.S. Geographic Distribution: Revenue Statistics by State

Market Size by State ($ millions) indicates how the industry's competition is distributed throughout the country. State-level information can identify areas with higher and lower industry market share than average.

U.S. map by state

Pharmaceutical Preparation Manufacturing Industry Price Trends

Rise and fall in market prices are affectedd by supply, demand, and the cost of goods/services sold. Higher demand or COGS will put upward price pressure on prices. Higher competition among Pharmaceutical Preparation Manufacturing companies will put a downward pressure on prices. The chart shows how prices are changing within the industry, month-to-month over the last three years.

example price index trendline

Income Statement (Average Financial Metrics)

Financial metrics provide a snapshot view of a benchmark "average" company. Key business metrics show revenue and operating costs. The data collected covers both public and private companies.

Industry AveragePercent of Sales
(Industry Benchmark)
Total Revenue

Order at top of page
Operating Revenue
Cost of Goods Sold
Gross Profit

Operating Expenses
Pension, profit sharing plans, stock, annuity
Rent paid on business property
Charitable Contributions
Domestic production activities deduction
Compensation of officers
Salaries and wages
Employee benefit programs
Taxes and Licenses
Bad Debts
Other Operating Expenses
Total Operating Expenses
Operating Income
Non-Operating Income
EBIT (Earnings Before Interest and Taxes)
Interest Expense
Earnings Before Taxes
Income Tax
Net Profit
Net Income
Source: AnythingResearch Analysis of U.S. federal statistics

Financial Ratio Analysis

Financial ratio information can be used to benchmark how a Pharmaceutical Preparation Manufacturing company compares to its peers. Accounting statistics are calculated from the industry-average for income statements and balance sheets.

Profitability & Valuation RatiosIndustry Average
Company valuation can be measured based on the firm's own performance, as well as in comparison against its industry competitors. These metrics show how the average company in the Pharmaceutical Preparation Manufacturing industry is performing.
Profit Margin
Gross Profit Margin, Operating Profit Margin, and Net Profit Margin. Show company earnings relative to revenues.
Return on Equity (ROE)
Return on Equity (ROE) is net income as a percentage of shareholders' equity. Shareholders' Equity is defined as the company's total assets minus total liabilities. ROE shows how much profits a company generates with the money shareholders invested (or with retained earnings).
Return on Assets (ROA)
Return on Assets (ROA) is net income relative to total assets. The market research on Pharmaceutical Preparation Manufacturing measures how efficiently the company leverages its assets to generate profit. ROA is calculated as Net Income divided by Total Assets.

Liquidity RatiosIndustry Average
Bankers and suppliers use liquidity to determine creditworthiness and identify potential threats to a company's financial viability.
Current Ratio
Measures a firm's ability to pay its debts over the next 12 months.
Quick Ratio (Acid Test)
Calculates liquid assets relative to liabilities, excluding inventories.

Efficiency Ratios - Key Performance IndicatorsIndustry Average
Measure how quickly products and services sell, and effectively collections policies are implemented.
Receivables Turnover Ratio
If this number is low in your business when compared to the industry average in the research report, it may mean your payment terms are too lenient or that you are not doing a good enough job on collections.
Average Collection Period
Based on the Receivables Turnover, this estimates the collection period in days. Calculated as 365 divided by the Receivables Turnover
Inventory Turnover
A low turnover rate may point to overstocking, obsolescence, or deficiencies in the product line or marketing effort.
Fixed-Asset Turnover
Generally, higher is better, since it indicates the business has less money tied up in fixed assets for each dollar of sales revenue.

Compensation & Salary Surveys for Employees

Compensation statistics provides an accurate assessment of industry-specific jobs and national salary averages. This information can be used to identify which positions are most common, and high, low, and average annual wages.

TitlePercent of WorkforceBottom Quartile Average (Median) SalaryUpper Quartile
Management Occupations 11%

Order at top of page
Chief Executives0%
General and Operations Managers2%
Business and Financial Operations Occupations 8%
Business Operations Specialists 7%
Architecture and Engineering Occupations 6%
Life, Physical, and Social Science Occupations 16%
Life Scientists 6%
Physical Scientists 6%
Chemists and Materials Scientists 6%
Chemists 6%
Office and Administrative Support Occupations 8%
Production Occupations 32%
Other Production Occupations 26%
Packaging and Filling Machine Operators and Tenders 9%
Packaging and Filling Machine Operators and Tenders 9%
Source: Bureau of Labor Statistics

Pharmaceutical Preparation Manufacturing Competitor Landscape & Key Companies [PREMIUM]

The most influential companies in the Pharmaceutical Preparation Manufacturing industry and adjacent industries either have large market share or are developing new business models and methods that could disrupt the status quo. We look at leading and emerging companies in the Pharmaceutical Preparation Manufacturing industry and adjacent sectors:

Market Leaders:
Direct Competitors

Companies with the largest market share, focused in this industry
Market leaders:
Diversified Competitors

Largest companies that have diversified operations in this and other industries
Direct Competitors

Innovative, Emerging, and Disruptive Companies that may influence the future direction of the industry.
Diversified Competitors

Innovators and Disruptors in adjacent industries that may also affect the Pharmaceutical Preparation Manufacturing industry.

Executive Briefings

  Competition in the pharmaceutical and biotechnology industries is intense. We face competition from a variety of companies focused on developing inflammatory, oncology and CV disease diagnostic imaging agents and other diagnostic modalities. We compete with large pharmaceutical and other specialized biotechnology companies. We also face competition from universities and other non-profit research organizations. Many emerging medical product companies have corporate partnership arrangements with large, established companies to support the research, development, and commercialization of products that may be competitive with our products. In addition, a number of large established companies are developing proprietary technologies or have enhanced their capabilities by entering into arrangements with or acquiring companies with technologies applicable to the detection or treatment of cancer and other diseases targeted by our product candidates. Smaller companies may also prove to be significant competitors, particularly through collaborative arrangements with large pharmaceutical and established biotechnology companies. Many of these competitors have products that have been approved or are in development and operate large, well-funded research and development programs. Many of our existing or potential competitors have substantially greater financial, research and development, regulatory, marketing, and production resources than we have. Other companies may develop and introduce products and processes competitive with or superior to ours.   We expect to encounter significant competition for our pharmaceutical products. Companies that complete clinical trials, obtain required regulatory approvals and commence commercial sales of their products before us may achieve a significant competitive advantage if their products work through a similar mechanism as our products and if the approved indications are similar. A number of biotechnology and pharmaceutical companies are developing new products for the treatment of the same diseases being targeted by us. In some instances, such products have already entered late-stage clinical trials or received FDA approval and may be marketed for some period prior to the approval of our products.   We believe that our ability to compete successfully will be based on our ability to create and maintain scientifically advanced “best-in-class” technology, develop proprietary products, attract and retain scientific personnel, obtain patent or other protection for our products, obtain required regulatory approvals and manufacture and successfully market our products, either alone or through third parties. We expect that competition among products cleared for marketing will be based on, among other things, product efficacy, safety, reliability, availability, price, and patent position. See Item 1A - “Risk Factors.”   Tc99m Tilmanocept Competition – Currently Approved Indications   Some surgeons who practice the lymphatic mapping procedure for which Tc99m tilmanocept is intended currently use other radiopharmaceuticals such as a sulfur colloid or other colloidal compounds. In the EU and certain Pacific Rim markets, there are colloidal-based compounds with various levels of approved labeling for use in lymphatic mapping, although a number of countries still employ products used “off-label.”   Rheumatoid Arthritis Competition   Currently, no single test is available to diagnose and monitor RA. Many of these drugs are produced and sold by large pharmaceutical companies, including AbbVie, Amgen, Bristol Meyers Squibb, Johnson Navidea Biopharmaceuticals

Government Contracts

In 2020, the federal government spent a total of $7,947,420,490 on Pharmaceutical Preparation Manufacturing. It has awarded 6573 contracts to 703 companies, with an average value of $11,305,008 per company.   

Most Recent Contracts Date Total Award Amount
6555 State Highway 161
Irving, TX
Jul 21, 2022$651,384,483

Related Reports

Can't find what you're looking for? We have over a thousand market research reports. Ask us and an analyst will help you find what you need.

Industries Related to Pharmaceutical Preparation Manufacturing

Pharmaceutical Preparation Manufacturing Market Report